Seqwell Inc.

Beverly, MA

UEI
DGMKSCUNLMA5
CAGE
75TX9
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
66 Cherry Hill Dr #100, Beverly, MA 01915, USA
Website
seqwell.com
Founded
2014
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $46,476
FY2024 $28,600
FY2023 $15,744

Contract awards

Similar vendors

About the company

Seqwell Inc. is a for-profit manufacturer of genomic sequencing products headquartered in Beverly, Massachusetts, with registered operations since June 2014. The company specializes in the design and production of sequencing kits and reagents that support genomic research, diagnostic activities, and disease surveillance initiatives across federal government agencies. Seqwell's product portfolio is tailored to meet the specialized needs of research institutions and public health organizations requiring advanced molecular biology tools for pathogen detection and genomic analysis.

Seqwell Inc. has established a consistent track record of federal contract awards totaling approximately $101,184 across multiple U.S. government agencies. The company's most recent contract, awarded on September 29, 2025, involved a $46,476 firm fixed-price purchase order from the U.S. Department of Agriculture's Plains Area for SeqWell Library Preparation Reagent supply, with completion scheduled for November 28, 2025. Prior to this, Seqwell received a $28,600 purchase order from the USDA Agricultural Research Service's Plains Area on February 16, 2024, for five sets of PlexWell PW384 Sequencing Kits, designated as a total small business set-aside contract and completed by April 16, 2024. The company has also provided sequencing reagents to the USDA's Veterinary Services division under a $15,744 contract awarded May 18, 2023, specifically supporting diagnostic investigations, genomic surveillance, and African Swine Fever Virus (ASFV) and Foot-and-Mouth Disease Virus (FMDV) preparedness initiatives. Additionally, Seqwell supplied library preparation products to the National Cancer Institute at the National Institutes of Health under a $10,364 purchase order dated June 29, 2021, designated for multiplexing library preparation applications. All contracts have been structured as firm fixed-price purchase orders, with the majority awarded without small business set-aside designations, though one small business set-aside contract demonstrates Seqwell's qualification as a small business concern within federal procurement frameworks.

Quick answers

Is Seqwell Inc. registered in SAM.gov?

Yes. Seqwell Inc.'s SAM.gov registration is active through November 10, 2026.

How much has Seqwell Inc. received in federal contracts?

Federal contracts obligated $46,476 to Seqwell Inc. in fiscal year 2025 and $90,820 in fiscal years 2023 through 2027.

How does Seqwell Inc. rank among federal contractors?

Seqwell Inc. ranked #74 in NAICS 325414 in FY2025.

What is Seqwell Inc.'s most recent federal award?

Seqwell Inc.'s most recent federal contract award is Seqwell library preparation reagent buy (1232SA25P0565), from Central Program Planning Coordination and Support (ARS), on September 29, 2025.

On GovTribe

See Seqwell Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors